Variant report
Variant | esv3461613 |
---|---|
Chromosome Location | chr3:24090670-24091144 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528953056 | chr3:24090741-24090742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548815239 | chr3:24090754-24090755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs13081986 | chr3:24090792-24090793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs13081989 | chr3:24090795-24090796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200888703 | chr3:24090799-24090800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201846320 | chr3:24090800-24090801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199642450 | chr3:24090801-24090802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200639919 | chr3:24090803-24090804 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201511346 | chr3:24090804-24090805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200101377 | chr3:24090805-24090806 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200478005 | chr3:24090807-24090808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540577461 | chr3:24090825-24090826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570245276 | chr3:24090833-24090834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560702266 | chr3:24090946-24090947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182213885 | chr3:24090977-24090978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570962444 | chr3:24091004-24091005 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185651688 | chr3:24091025-24091026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534713804 | chr3:24091028-24091029 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553304774 | chr3:24091039-24091040 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78046038 | chr3:24091101-24091102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24088200-24091400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr3:24088400-24091800 | Enhancers | NHDF-Ad | bronchial |
3 | chr3:24088600-24090800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr3:24088800-24090800 | Enhancers | Adipose Nuclei | Adipose |
5 | chr3:24088800-24090800 | Enhancers | Placenta | Placenta |
6 | chr3:24088800-24090800 | Enhancers | Ovary | ovary |
7 | chr3:24088800-24090800 | Enhancers | HMEC | breast |
8 | chr3:24088800-24090800 | Enhancers | NHLF | lung |
9 | chr3:24088800-24091400 | Enhancers | HSMMtube | muscle |
10 | chr3:24089800-24091600 | Weak transcription | Psoas Muscle | Psoas |
11 | chr3:24089800-24092800 | Weak transcription | A549 | lung |
12 | chr3:24090800-24093600 | Weak transcription | Ovary | ovary |
13 | chr3:24090800-24101400 | Weak transcription | NHLF | lung |